Please login to the form below

Not currently logged in
Email:
Password:

Teva appoints Timothy Wright as business development head

The former Covidien Pharma president mostrecently led a US cancer centre

Teva has appointed Timothy Wright as its new head of business development, strategy and innovation.

He joins the Israeli pharma company from The Ohio State University Comprehensive Cancer Center, where he served as director of its Drug Discovery and Development Institute.

Prior to that Wright spent more than 25 years in pharma and biotech, most recently as president of Covidien Pharma from 2007-10.

Before that he was CEO (Interim) and Presidentat AAI Pharmaceuticals/Xanodyne and held various roles at Elan Pharmaceuticals and DuPont Merck Pharmaceutical Company.

In his new, newly-created role Wright, whose appointment will be effective from April 13, will be responsible for identifying new sources of innovation and growth that are extensions of Teva's current business model.

Erez Vigodman, Teva's president and CEO, said: “The addition of Tim to our leadership team complements the strong management capabilities we have in Teva. He has a wealth of global experience which will serve us well as we look to create a new and exciting future for Teva.

“Tim is known for leading the transformation of large companies. His significant experience across various aspects of healthcare and unique perspective will enable us to realise our full potential at this critical time of change in the pharmaceutical industry.”

26th March 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS Just::

HAVAS Just:: is a different kind of healthcare communications agency. Our mission is to create campaigns that make people think....

Latest intelligence

The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments
The essential medicine list (EML) contains treatments considered to be the most effective and safe in targeting global health concerns. On 9 July 2019, the World Health Organization (WHO) published...
NICE
Evolution or revolution: the latest review of NICE methods
By Leela Barham...
PRO
Integrating patient reported outcomes into clinical trials
How capturing the patient voice is unlocking medicines’ commercial potential...

Infographics